We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Crucial Biomarker Discovery to Enable Early Diagnosis of Chronic Renal Failure

By LabMedica International staff writers
Posted on 27 May 2025

Millions of tiny blood vessels, known as peritubular capillaries, play a crucial role in kidney function by filtering waste from the blood and supplying oxygen and nutrients to the organ. More...

Kidney injuries, which occur when blood flow is temporarily interrupted and then restored, can lead to a loss of these essential blood vessels, significantly impairing kidney function. The reduction in peritubular capillaries is a definitive marker of chronic renal failure, a condition that affects millions globally. Until now, no reliable biomarker has been available to assess the health of these capillaries or to create targeted strategies to preserve kidney function. In a groundbreaking discovery, scientists have identified a specific microRNA that can protect small blood vessels and support kidney function following severe injury. This breakthrough has the potential to revolutionize early diagnosis and the prevention of kidney disease.

The research team at the University of Montreal Hospital Research Centre (CRCHUM, Montreal, Canada) found that the miR-423-5p microRNA could serve as a promising biomarker in the blood to predict the health of kidney microvasculature. They first observed fluctuating levels of miR-423-5p microRNA in the blood of mice with acute kidney injuries. These findings were confirmed in 51 transplant recipients who participated in the CHUM kidney transplant biobank. In a study published in JCI Insight, the team demonstrated how the biomarker could be used to assess the effects of interventions on the health of small blood vessels. By utilizing this biomarker, it is now possible to develop a test that can detect microvascular health much earlier, enabling healthcare providers to evaluate high-risk patients more effectively. This includes elderly patients or those undergoing surgeries that temporarily halt blood flow, such as organ transplants or cardiovascular procedures.

Furthermore, the researchers discovered that by injecting miR-423-5p microRNA into mice with kidney injuries, they were able to protect the small blood vessels and limit kidney damage. While directly injecting the microRNA into the kidney is a feasible approach during transplant procedures, the team is now focusing on exploring alternative methods to deliver the microRNA, or possibly a combination of microRNAs, to the kidney. In terms of prevention, a test based on the miR-423-5p microRNA could be beneficial for patients with conditions such as heart failure, lung failure, or specific neurodegenerative diseases. The researchers also suggest that the CHUM’s biobank of biological materials could be used to investigate whether existing medications, taken after a kidney transplant to treat other issues, affect the health of small blood vessels.


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Shaking Incubator
Corning LSE 71L
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Microbiology

view channel
Image: The U.S. FDA-cleared IntelliSep rapid host response diagnostic represents a breakthrough in sepsis care (Photo courtesy of Cytovale)

Rapid Diagnostic Test Slashes Sepsis Mortality by 39%

Sepsis remains one of the most challenging and fatal conditions in contemporary healthcare, accounting for nearly one-third of all hospital-related deaths in the United States. In emergency departments... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.